Abstract:Non-small cell lung cancer (NSCLC) is the second most common cancer and accounts for ~127,000 deaths/year in the U.S. Its current ~30% five-year survival rate is an improvement from a decade ago thanks in part to the introduction of immune checkpoint inhibitors including PD1- and PD-L1-specific monoclonal antibodies. While PD-1/PD-L1-targeted immunotherapy is effective in many cases, not all patients respond and complete remissions still only occur in a minority of patients. Therefore, a greater understanding of immune checkpoint regulation in human NSCLC is needed. Here, we investigated a novel role for the aryl hydrocarbon receptor (AhR), an environmental carcinogen receptor previously associated with smoking-induced lung cancers, in the regulation of immune checkpoints PD-L1, PD-L2, and IDO1. Computational analyses of existing databases for protein-protein interactions linked to the AhR signaling pathway suggested crosstalk between the AhR, type I and type II Interferon (IFN), and JAK/STAT signaling pathways. AhR deletion from human lung A549 adenocarcinoma cells significantly reduced expression of JAK2, STAT1, STAT2, and the JAK/STAT signaling targets IRF1 and IRF9. Type II IFNγ significantly increased expression of those genes as well as the immune checkpoints IDO1, PD-L1, and PD-L2 in an AhR-dependent fashion. Interestingly, AhR deletion also eliminated IFNγ-mediated induction of a recently described long non-coding RNA, INCR1, which is encoded across the CD274/CD273 locus, and which facilitates JAK2, CD274/PD-L1, and IDO1 translation. Concomitantly, AhR knockout increased baseline expression of an RNA-binding protein, HNRNPH1, known to sequester JAK2 and CD274 mRNA thereby reducing IDO, PD-L1 and PD-L2 expression. Similarly, the AhR was shown to regulate Type I IFNα-mediated induction of STAT1, STAT2, CD274/PD-L1, and CD273/PD-L2. The data indicate that IFN induction of key immune checkpoints in lung adenocarcinoma cells is dependent on the AhR through its control of a conventional JAK/STAT pathway and an unconventional lncRNA (INCR1) and RNA-binding protein (HNRNPH1) pathway. Citation Format: Brian Lara, Megan Snyder, Zhongyan Wang, Jocelyn Fimbres, Eric Yang, David H. Sherr. A new role for the aryl hydrocarbon receptor (AhR) as a proximal mediator of immune checkpoints (PD-L1/2 and IDO1) in non-small cell lung cancer: Insights into an interferon-induced, LncRNA-and JAK/STAT-mediated signaling pathway [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2649.

APLNR regulates IFN-γ signaling via β-arrestin 1 mediated JAK-STAT1 pathway in melanoma cells

Enhanced IFN Sensing by Aggressive Chronic Lymphocytic Leukemia Cells

APLNR inhibited nasopharyngeal carcinoma growth and immune escape by downregulating PD-L1

MicroRNA-181a-mediated Downregulation of AC9 Protein Decreases Intracellular Camp Level and Inhibits ATRA-induced APL Cell Differentiation

APLN Promotes the Proliferation, Migration, and Glycolysis of Cervical Cancer Through the PI3K/AKT/mTOR Pathway

Silencing APLNR enhances the radiosensitivity of prostate cancer by modulating the PI3K/AKT/mTOR signaling pathway

Modulation Of Ifn-Gamma Receptor 1 Expression By Ap-2 Alpha Influences Ifn-Gamma Sensitivity Of Cancer Cells

AIP1 Functions As a Negative Regulator in Flow‐mediated Vascular Remodeling

Modulation of IFN-γ receptor 1 expression by AP-2α influences IFN-γ sensitivity of cancer cells.

Abstract 2649: A new role for the aryl hydrocarbon receptor (AhR) as a proximal mediator of immune checkpoints (PD-L1/2 and IDO1) in non-small cell lung cancer: Insights into an interferon-induced, LncRNA-and JAK/STAT-mediated signaling pathway

lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway

Cancer apelin receptor suppresses vascular mimicry in malignant melanoma

Reciprocal Interactions Between Apelin and Noncoding RNAs in Cancer Progression

NLRP3 inflammasome in immune cells regulates metastatic potential of cancer

Interferon-gamma signaling promotes melanoma progression and metastasis

FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity

IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph Nodes

NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma

NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma

IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma

Apelin/APJ signaling activates autophagy to promote human lung adenocarcinoma cell migration